Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • SUBSCRIBE

G-CON and GE Healthcare to Collaborate on Next Generation Modular Bio-therapeutic Manufacturing Technology

By Pharmaceutical Processing | December 2, 2010

Texas-based G-Con Manufacturing, LLC and GE Healthcare, a
unit of General Electric Company, announced today their intention to
collaborate on the development of an industry-leading modular portable
bio-process manufacturing solution for vaccines and therapeutics.

This collaboration combines GE Healthcare’s global presence
and expertise in biopharmaceutical manufacturing technology with G-Con’s
modular portable flexible clean-room technology. The collaboration will offer
comprehensive GMP manufacturing solutions that are less expensive and quicker
to build and maintain and easier to operate than any currently existing
solution on the market. 

Together, the companies have the capability to design, build
and deliver turnkey advanced bio-therapeutic manufacturing facilities
throughout the world, and will be able to meet the growing market for rapid
access to biopharmaceutical manufacturing capabilities, whether in developing
markets, or for increased speed in situations such as pandemic response.

“GE Healthcare is a global life sciences leader, and we are
excited by the market-changing next generation therapeutic manufacturing
innovations this collaboration will be able to produce,” said Dr. Barry Holtz,
President of G-Con Manufacturing, LLC.

“This collaboration is part of GE Healthcare’s mission to
increase speed and access, and reduce cost for developers and manufacturers of
bio-therapeutics and vaccines around the world,” said Nigel Darby, Vice
President, Biotechnologies, GE Healthcare. “This collaboration means we move
further towards our vision of modular and possibly mobile flexible
bio-pharmaceutical manufacturing facilities – the vaccine factory in a box.”

 

Related Articles Read More >

GSK
GSK invests another $800M in Pennsylvania site expansions
This is a BD image of its major IV catheters manufacturing facility in Sandy, Utah, which the company said produces billions of molded components each year.
BD to invest billions in U.S. manufacturing
Diverse factory workers in yellow PPE suits checking production data with clipboard in modern industrial facility, Quality control inspector wearing masks and hairnets working in food or pharma plant
ISO 9001, 14001 and 45001 revisions: What changes and when to start
Artis BioSolutions announces new center of excellence in Spain
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2026 Arrowfly LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • SUBSCRIBE